Chronic Obstructive Pulmonary Disease (COPD)
COPD is a major global health problem and is predicted to be the third commonest cause of death worldwide by 2030.
COPD is characterised by airflow obstruction that is slowly progressive and persistent. This is easily measurable with spirometry, and the rate of decline in FEV1 predicts morbidity and mortality.
Severity of COPD is based upon a combination of factors including symptoms, functional disability, rate of decline of FEV1, presence of respiratory failure, the number of exacerbations and whether they require hospital admission.
Stopping smoking continues to be the most cost-effective way of preventing COPD.
KeywordsChronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Patient Fluticasone Propionate Airflow Obstruction Chronic Obstructive Pulmonary Disease Exacerbation
- 1.National Institute for Health and Care Excellence. COPD guideline CG 101 (Published 2010 and revised 2014). www.nice.org.uk.
- 3.Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (Revised 2011).Google Scholar
- 5.Lareau SC, ZuWallack R, et al. Pulmonary rehabilitation: official statement of the American Thoracic Society. Am J Respir Crit Care Med. 1999;159:1666–82.Google Scholar